Skip to main content

Digitalis Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

72
Companies
$1.6B
Total invested
$35.7M
Avg. check
36
Industries
Health Care 13Biotechnology 12Medical 11Therapeutics 5Pharmaceutical 3Life Science 3+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 72
PetMedix
September 2021

PetMedix is a pet therapeutics startup.

Biotechnology · Cambridge$37.2M Series B
Base5 Genomics
September 2021

Base5 Genomics is a developer of sequencing solutions used for personalized care.

Biotechnology · Mountain View$4.2M Seed
UnifiHealth
September 2021

UnifiHealth is reimagining how health benefits are built and delivered to small businesses.

Employee Benefits · Columbus$5.4M Seed
Poppins Health
September 2021

Poppins Health provides primary care, prescription drugs, and behavioral health services.

Health Care · Columbus$5.4M Seed
Transcera
July 2023

Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.

Biotechnology · Jamaica PlainSeed
ASTRA Therapeutics
July 2025

ASTRA Therapeutics is a medication development business that uses cutting-edge science and technology.

Health Care · Villigen$9.7M Seed
GRO Biosciences
July 2024

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Biotechnology · Boston$60.3M Series B
Cardurion Pharmaceuticals
July 2024

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Biotechnology · Boston$260.0M Series B
Rejuvenate Bio
June 2026

Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

Biotechnology · San Diego$6.0M Venture - Series Unknown
Omni
June 2026

Omni is a plant-based pet food company from the UK, that is developing healthy, sustainable food for dogs.

Animal Feed · London$14.6M Series A
Neion Bio
June 2026

Neion Bio uses advances in stem cell biology and genetic engineering to completely reimagine the biopharmaceutical production process.

Yorkshire$23.0M Series A
Travv
May 2026

Travv is a startup focused on veterinary diagnostics powered by AI.

Stillwater$1.6M Seed
Elemental Machines
May 2026

Elemental Machines delivers data-driven insights that improves R&D, laboratory operations, and manufacturing outcomes.

Artificial Intelligence (AI) · Cambridge$5.7M Series B
Code Ocean
May 2022

Code Ocean is a computational research platform that aims to help researchers replicate data-heavy science.

Information Services · New York$16.5M Series B
Scratch
May 2026

Scratch empowers medical practices to seamlessly connect and transact with their clients

Finance · PasadenaDebt Financing
Ness
May 2022

The card that keeps you healthy. Request an invite to Ness Rewards at www.nesswell.com.

Financial Services · New York$15.5M Seed
Bonum Therapeutics
April 2026

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

Biotechnology · Seattle$26.9M Venture - Series Unknown
Girihlet
March 2022

Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.

Biotechnology · Brooklyn$500K Debt Financing
Ascend Gene & Cell Therapies
March 2023

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Biotechnology · Potters Bar$65.9M Series A
Nadia Care
March 2026

Nadia Care is a maternal health company dedicated to supporting moms throughout their pregnancy and after their baby is born.

Health Care · Philadelphia$12.0M Series Unknown
Made by Nacho
February 2022

Made by Nacho is an e-commerce company that delivers cat-crafted, feline-only cat food with natural vitamins and minerals.

Animal Feed · New York$14.0M Series A
Faeth Therapeutics
October 2025

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Biotechnology · San Francisco$25.0M Series A
Positive Development
August 2025

Positive Development is improving lives by helping develop the skills to connect with one’s self, family, and community.

Children · Mclean$51.5M Series C
Galatea Bio
March 2025

Galatea Bio's mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Artificial Intelligence (AI) · Miami Lakes$8.0M Venture - Series Unknown

Where Digitalis Ventures invests

Health Care13
Biotechnology12
Medical11
Therapeutics5
Pharmaceutical3
Life Science3

About Digitalis Ventures's portfolio

How many companies has Digitalis Ventures invested in?

Digitalis Ventures has invested in 72 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Digitalis Ventures invest in?

Digitalis Ventures's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Pharmaceutical. The firm invests across 36 different industry categories.

What is Digitalis Ventures's largest investment?

Among tracked funding rounds, Cardurion Pharmaceuticals received $260.0M in a Series B round. Digitalis Ventures's total known invested capital is $1.6B.

What is the average investment size for Digitalis Ventures?

Digitalis Ventures's average investment size is $35.7M across its portfolio of 72 companies.

What are Digitalis Ventures's most recent investments?

Recent Digitalis Ventures portfolio additions include PetMedix, Base5 Genomics, UnifiHealth, Poppins Health, Transcera. These companies were founded in 2020 or later.

Reach the founders behind these 72 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →